Elevating Quality of Life with Advanced Drug Delivery

From Molecule to Market

Delivering Value for Every Stakeholder

Contract Manufacturers
Pharmaceutical Companies
Wholesalers
Independent Pharmacies
Patients

U.S. Market Access

We buy and resell CMO/CDMO products through our established distribution network.

Regulatory Expertise for Foreign CMOs

We fill FDA regulatory gaps, helping foreign CMOs bring products to the U.S.

Product Innovation & Risk Sharing

We invest in product development, sometimes from the ground up, taking on the full financial risk.

Strategic Co-development

We use targeted ABM campaigns to partner with CMOs for approval initiatives, focusing on long-term growth.

Direct Distribution

We bypass large wholesalers, delivering products directly to prescribers and pharmacies.

Channel Access

We provide an alternative distribution network, enhancing market presence.

In-licensing Partnerships

We license select products that align with our sales channel and target market.

Strategic Collaboration

While co-development is rare, we collaborate on select market-expansion initiatives.

Specialty Product Supply

We focus on high-demand, patient-friendly medications.

Streamlined Partnerships

Fast, reliable logistics and customer-first support.

Sales Enablement

We help wholesalers position and sell TerrainRx products effectively.

Access Through Preferred Wholesalers

Pharmacies can source our products through their usual channels.

Patient-focused Products

Medications designed for ease of use, improved adherence, and positive clinical outcomes.

Pharmacy Profitability

Cost-effective, cGMP-compliant products with stable reimbursement models.

Targeted Local Support

We offer marketing and clinical awareness strategies when needed — without overcomplicating.

User-friendly Products

We prioritize ease of use, adherence, and improved quality of life.

Multiple Access Points

Available through independent pharmacies, medical practices, and, soon, telehealth.

Affordability & Coverage

We aim to minimize out-of-pocket costs and maximize insurance coverage.

Who We Are

Founded in 2012 and headquartered in Reno, Nevada, Terrain Pharmaceuticals, Inc. focuses on the final stretch of drug development - combining formulation expertise, regulatory insight, and data-driven distribution to carry late-stage therapies from lab validation to the pharmacy counter.

That capability now powers a seamless, end-to-end platform: cGMP manufacturing on four continents, FDA-seasoned regulatory teams, and a nationwide channel connecting specialty wholesalers, 6,000-plus prescribers, and independent pharmacies. Whether guiding a first-time U.S. launch or refreshing a late-lifecycle product for renewed market traction, Terrain accelerates launch timelines, protects margins, and always keeps patient benefit front and center.

What Sets Us Apart

Quality Without Compromise

• cGMP partners in the U.S., EU, India & Asia
• Rigorous quality testing at every stage
• Dedicated Quality Unit with live lot tracking

Platform Innovation

• Hydrogel & drug-in-adhesive patches for steady, skin-friendly delivery
• Enhanced-bioavailability softgels
• Transmucosal formats to bypass first-pass metabolism

Targeted Distribution

National specialty wholesalers for breadth, plus physician-dispensed and independent-pharmacy programs for depth

Commercial Agility

• Complete regulatory pathways – ANDA, 505(b)(2), OTC
• Turnkey pricing, chargeback & compendia setup
• Flexible deal structures: licensing, co-promotion, asset acquisition

Stakeholder-Centric Benefits

Pharma / Brand Owners

Rapid U.S. entry, channel expansion, lifecycle extensions, liquidity for dormant ANDAs

CMOs / CDMOs

Capital backed scale up, tech transfer expertise, guaranteed off-take volumes

Specialty Wholesalers

Differentiated SKUs, predictable lead times, collaborative marketing support

Independent Pharmacies

Stable reimbursement, special-order speed, 
co-branded patient education

Patients & Providers

Comfort-first formulations and delivery systems that lower systemic side effects and fit daily life

By The Numbers

20+ products

in active development across hydrogel & DIA patches, tablets, capsules and soft gels

10 launches

slated for 2025 covering pain, sleep, and supportive-care categories

8 manufacturing sites

across 4 continents provide supply resilience

3,000+ clinics

reached via physician-services channel, plus coast-to-coast wholesale coverage

Growth Pipeline Snapshot

2025 launch wave: Stool softener soft gel; patches for PHN, NSAID, and sleep

Next-gen drug-in-adhesive matrix and new line extensions in development

Selective licensing or acquisition of ANDA & 505(b)(2) assets to accelerate revenue

See the full roadmap on our

Pipeline